High resolution proton nuclear magnetic resonance spectroscopy ( 1H MRS) can be used to detect biochemical changes in vitro caused by distinct pathologies. It can reveal distinct metabolic profiles of brain tumors although the accurate analysis and classification of different spectra remains a challenge. In this study, the pattern recognition method partial least squares discriminant analysis (PLS-DA) was used to classify 11.7 T 1H MRS spectra of brain tissue extracts from patients with brain tumors into four classes (high-grade neuroglial, low-grade neuroglial, non-neuroglial, and metastasis) and a group of control brain tissue. PLS-DA revealed 9 metabolites as the most important in group differentiation: γ-aminobutyric acid, acetoacetate, alanine, creatine, glutamate/glutamine, glycine, myo-inositol, N-acetylaspartate, and choline compounds. Leave-one-out crossvalidation showed that PLS-DA was efficient in group characterization. The metabolic patterns detected can be explained on the basis of previous multimodal studies of tumor metabolism and are consistent with neoplastic cell abnormalities possibly related to high turnover, resistance to apoptosis, osmotic stress and tumor tendency to use alternative energetic pathways such as glycolysis and ketogenesis.442149164http://www.cancer.org/, American Cancer SocietyPerry, T.L., Hansen, S., Gandham, S.S., Postmortem changes of amino compounds in human and rat brain (1981) J Neurochem, 36, pp. 406-410Martinez-Bisbal, M.C., Marti-Bonmati, L., Piquer, J., Revert, A., Ferrer, P., Llacer, J.L., 1H and 13C HR-MAS spectroscopy of intact biopsy samples ex vivo and in vivo 1H MRS study of human high grade gliomas (2004) NMR Biomed, 17, pp. 191-205Garcia-Gomez, J.M., Luts, J., Julia-Sape, M., Krooshof, P., Tortajada, S., Robledo, J.V., Multiproject-multicenter evaluation of automatic brain tumor classification by magnetic resonance spectroscopy (2009) MAGMA, 22, pp. 5-18Tate, A.R., Underwood, J., Acosta, D.M., Julia-Sape, M., Majos, C., Moreno-Torres, A., Development of a decision support system for diagnosis and grading of brain tumours using in vivo magnetic resonance single voxel spectra (2006) NMR Biomed, 19, pp. 411-434Wright, A.J., Arus, C., Wijnen, J.P., Moreno-Torres, A., Griffiths, J.R., Celda, B., Automated quality control protocol for MR spectra of brain tumors (2008) Magn Reson Med, 59, pp. 1274-1281Julia-Sape, M., Acosta, D., Mier, M., Arus, C., Watson, D., A multi-centre, web-accessible and quality control-checked database of in vivo MR spectra of brain tumour patients (2006) MAGMA, 19, pp. 22-33Solivera, J., Cerdan, S., Pascual, J.M., Barrios, L., Roda, J.M., Assessment of 31P-NMR analysis of phospholipid profiles for potential differential diagnosis of human cerebral tumors (2009) NMR Biomed, 22, pp. 663-674Govindaraju, V., Young, K., Maudsley, A.A., Proton NMR chemical shifts and coupling constants for brain metabolites (2000) NMR Biomed, 13, pp. 129-153Geladi, P., Kowalski, B.R., Partial least squares regression: A tutorial (1986) Anal Chim Acta, 185, pp. 1-17Ferreira, M.M.C., Antunes, A.M., Melo, M.S., Volpe, P.L.O., Chemometrics I: Multivariate calibration, a tutorial (1999) Quím Nova, 22, pp. 724-731Sharipo, A., Imreh, M., Leonchiks, A., Imreh, S., Masucci, M.G., A minimal glycine-alanine repeat prevents the interaction of ubiquitinated I kappaB alpha with the proteasome: A new mechanism for selective inhibition of proteolysis (1998) Nat Med, 4, pp. 939-944Lemasters, J.J., Qian, T., He, L., Kim, J.S., Elmore, S.P., Cascio, W.E., Role of mitochondrial inner membrane permeabilization in necrotic cell death, apoptosis, and autophagy (2002) Antioxid Redox Signal, 4, pp. 769-781Lehnhardt, F.G., Rohn, G., Ernestus, R.I., Grune, M., Hoehn, M., 1H- and 31P-MR spectroscopy of primary and recurrent human brain tumors in vitro: Malignancy-characteristic profiles of water soluble and lipophilic spectral components (2001) NMR Biomed, 14, pp. 307-317Brand, A., Richter-Landsberg, C., Leibfritz, D., Multinuclear NMR studies on the energy metabolism of glial and neuronal cells (1993) Dev Neurosci, 15, pp. 289-298Majos, C., Aguilera, C., Alonso, J., Julia-Sape, M., Castaner, S., Sanchez, J.J., Proton MR spectroscopy improves discrimination between tumor and pseudotumoral lesion in solid brain masses (2009) AJNR Am J Neuroradiol, 30, pp. 544-551Loening, N.M., Chamberlin, A.M., Zepeda, A.G., Gonzalez, R.G., Cheng, L.L., Quantification of phosphocholine and glycerophosphocholine with 31P edited 1H NMR spectroscopy (2005) NMR Biomed, 18, pp. 413-420Gambarota, G., Mekle, R., Xin, L., Hergt, M., van der Zwaag, W., Krueger, G., In vivo measurement of glycine with short echo-time 1H MRS in human brain at 7 T (2009) MAGMA, 22, pp. 1-4Lehnhardt, F.G., Bock, C., Rohn, G., Ernestus, R.I., Hoehn, M., Metabolic differences between primary and recurrent human brain tumors: A 1H NMR spectroscopic investigation (2005) NMR Biomed, 18, pp. 371-382Otsuki, T., Nakama, H., Kanamatsu, T., Tsukada, Y., Glutamate metabolism in epilepsy: 13C-magnetic resonance spectroscopy observation in the human brain (2005) Neuroreport, 16, pp. 2057-2060Urenjak, J., Williams, S.R., Gadian, D.G., Noble, M., Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neural cell types (1993) J Neurosci, 13, pp. 981-989Peeling, J., Sutherland, G., High-resolution 1H NMR spectroscopy studies of extracts of human cerebral neoplasms (1992) Magn Reson Med, 24, pp. 123-136Poptani, H., Gupta, R.K., Jain, V.K., Roy, R., Pandey, R., Cystic intracranial mass lesions: Possible role of in vivo MR spectroscopy in its differential diagnosis (1995) Magn Reson Imaging, 13, pp. 1019-1029Demir, M.K., Iplikcioglu, A.C., Dincer, A., Arslan, M., Sav, A., Single voxel proton MR spectroscopy findings of typical and atypical intracranial meningiomas (2006) Eur J Radiol, 60, pp. 48-55Rothman, D.L., Behar, K.L., Hetherington, H.P., Shulman, R.G., Homonuclear 1H double-resonance difference spectroscopy of the rat brain in vivo (1984) Proc Natl Acad Sci U S A, 81, pp. 6330-6334Bernasconi, A., Tasch, E., Cendes, F., Li, L.M., Arnold, D.L., Proton magnetic resonance spectroscopic imaging suggests progressive neuronal damage in human temporal lobe epilepsy (2002) Prog Brain Res, 135, pp. 297-304Petroff, O.A., Errante, L.D., Kim, J.H., Spencer, D.D., N-acetyl-aspartate, total creatine, and myo-inositol in the epileptogenic human hippocampus (2003) Neurology, 60, pp. 1646-1651Gill, M., Miller, S.L., Evans, D., Scatliff, J.H., Meyerand, M.E., Powers, S.K., Magnetic resonance imaging and spectroscopy of small ring-enhancing lesions using a rat glioma model (1994) Invest Radiol, 29, pp. 301-306Simister, R.J., McLean, M.A., Barker, G.J., Duncan, J.S., Proton magnetic resonance spectroscopy of malformations of cortical development causing epilepsy (2007) Epilepsy Res, 74, pp. 107-115Sabatier, J., Gilard, V., Malet-Martino, M., Ranjeva, J.P., Terral, C., Breil, S., Characterization of choline compounds with in vitro 1H magnetic resonance spectroscopy for the discrimination of primary brain tumors (1999) Invest Radiol, 34, pp. 230-235Miller, B.L., Chang, L., Booth, R., Ernst, T., Cornford, M., Nikas, D., In vivo 1H MRS choline: Correlation with in vitro chemistry/ histology (1996) Life Sci, 58, pp. 1929-1935Usenius, J.P., Kauppinen, R.A., Vainio, P.A., Hernesniemi, J.A., Vapalahti, M.P., Paljarvi, L.A., Quantitative metabolite patterns of human brain tumors: Detection by 1H NMR spectroscopy in vivo and in vitro (1994) J Comput Assist Tomogr, 18, pp. 705-713Gallego-Ortega, D., De Ramirez, M.A., Gutierrez, R., Ramos, M.A., Sarmentero, J., Cejas, P., Generation and characterization of monoclonal antibodies against choline kinase alpha and their potential use as diagnostic tools in cancer (2006) Int J Oncol, 29, pp. 335-340Ravi, R., Mookerjee, B., Bhujwalla, Z.M., Sutter, C.H., Artemov, D., Zeng, Q., Regulation of tumor angiogenesis by p53- induced degradation of hypoxia-inducible factor 1 alpha (2000) Genes Dev, 14, pp. 34-44Gracey, A.Y., Troll, J.V., Somero, G.N., Hypoxia-induced gene expression profiling in the euryoxic fish Gillichthys mirabilis (2001) Proc Natl Acad Sci U S A, 98, pp. 1993-1998Huang, L.E., Bunn, H.F., Hypoxia-inducible factor and its biomedical relevance (2003) J Biol Chem, 278, pp. 19575-19578Jogi, A., Ora, I., Nilsson, H., Lindeheim, A., Makino, Y., Poellinger, L., Hypoxia alters gene expression in human neuroblastoma cells toward an immature and neural crest-like phenotype (2002) Proc Natl Acad Sci U S A, 99, pp. 7021-7026Seagroves, T.N., Ryan, H.E., Lu, H., Wouters, B.G., Knapp, M., Thibault, P., Transcription factor HIF-1 is a necessary mediator of the Pasteur effect in mammalian cells (2001) Mol Cell Biol, 21, pp. 3436-3444Petroff, O.A., Ogino, T., Alger, J.R., High-resolution proton magnetic resonance spectroscopy of rabbit brain: Regional metabolite levels and postmortem changes (1988) J Neurochem, 51, pp. 163-171Stanley, J.A., Cendes, F., Dubeau, F., Andermann, F., Arnold, D.L., Proton magnetic resonance spectroscopic imaging in patients with extratemporal epilepsy (1998) Epilepsia, 39, pp. 267-273